STROKE Stroke is an injury to the brain caused by occlusion or rupture of a cerebral artery Third most common cause of death & most leading cause of adult disability Challenges of stroke prevention & care are particularly compelling for geriatricians Most significant risk factor for stroke is AGE Prof. DAHAB Stroke 2 MAJOR CATEGORIES OF STROKE ISCHEMIC STROKE: Results from thrombosis (65%) or embolism (25%) 2. HAEMORRHAGIC STROKE: Due to intracerebral hemorrhage (95%) or subarachnoid hemorrhage (5%) 1. Prof. DAHAB Stroke 3 MODE OF ONSET THROMBOTIC: variable onset, preceded by TIA’s ± step-wise (stroke in evolution) EMBOLIC: Sudden with maximal deficit from start INTRACEREBRAL HGE: Sudden onset + ⇑ BP & during activity SAH: Sudden crushing headache proceeds to coma Prof. DAHAB Stroke 4 MAJOR CLINICAL SYNDROMES OF STROKE MCA ACA PCA ICA VBA Prof. DAHAB Stroke 5 MCA Contra lateral hemiplegia + hemilyposthene. Contra lateral homonymous hemiaropia APHASIA (dominant hemisphere) AFFECTIVE DISTURBANCE (non dominant hemisphere) NEGLECT: Failure to respond to contra lateral stimuli Prof. DAHAB Stroke 6 ACA Contra lateral leg/foot paralysis Gait disturbances Ideomotor apraxia Preservation Urinary incontinence Prof. DAHAB Stroke 7 PCA Contra lateral hemiparesis & hemihypothesia Contralateral homonymus hemianopia Memory impairment Dyslexia Brain stem signs: 3rd, cranial nerve palsy ± ataxia Prof. DAHAB Stroke 8 ICA Transient monocular blindness Homonymus hemianopia Aphasia (dominant hemisphere) Neglect (non-dominant hemisphere) Signs of MCA, ACA, ± PCA ischemia Prof. DAHAB Stroke 9 VBAs – Ipsilateral cerebellar ataxia ± nystagmus – Nausea & vomiting ± vertigo – Contralateral hemiplegia & hemihyposthesia – Intranuclear opthalmoplegia ± deafness – “Locked-in” syndrome (conscious + quadriplegia) Prof. DAHAB Stroke 10 LACUNAR SYNDROMES Pure motor hemiparesis Pure sensory stroke Dysartheria / clumsy hand syndrome Hemichorea / hemiballismus Homolateral ataxia & crural paresis Prof. DAHAB Stroke 11 STROKE AETIOLOGY THROMBOTIC: Atherosclerotic plague ± polycythemia. EMBOLIC: Cardiac source or atherosclerotic plagues INTRACEREBRAL HGE: Rupture penetrating vessels by HTN or hemorrhagic conversion of infarct SUBARACHNOID HGE: Cerebral aneurysm ± AVM LACUNAR STROKE: AGE, DM & HTN Prof. DAHAB Stroke 12 DD of TIAs or STROKE Seizures Syncope Migraine Subdural hematoma Brain tumor Hypoglycemia Demyelinating disease Brain abscess Encephalitis Panic attacks Prof. DAHAB Stroke 13 Non-Modifiable Risk Factors Age Male Africans Hereditary Prof. DAHAB Stroke 14 MODIFIABLE RISK FACTORS Hypertension AF DM Smoking Hyperlipidemia 4 times 16 times 4 times 2 times & physical inactivity (uncertain) Prof. DAHAB Stroke 15 OTHER POTENTIAL RISK FACTORS Atrial septal aneurysm Patent foramen ovale Aortic arch atheroma Anticardiolipin antibodies Chronic inflammation Prof. DAHAB Stroke 16 OPTIONS for PRIMARY PREVENTION Coronary artery disease HTN DM Hyperlipidemia Tobacco abuse Obesity Prof. DAHAB Stroke 17 ANTICOAGULATION in PRIMARY PREVENTION? Cardiac source for embolic stroke e.g. AF ⇒ Warfarin People over 75 share in decreased risk of embolization Antiplatelet therapy with aspirin 325 mg daily ⇒ ⇓ Risk of stroke with AF ⇒ Half efficacy than Warfarin Prof. DAHAB Stroke 18 Initial management of acute stroke Rapid clinical evaluation ⇒ Thrombolytic therapy: tissue-type plasminogen activator <3 hours Emergency ECG, chest X-ray, CBC, bleeding profile, ESR & ABG Distinguish hge from infarction ASAP ⇒ noncontrast CT & urgent interpretation Diffusion-weighted MRI & perfusion imaging ⇒ detect within min the territory undergoing ischemia Prof. DAHAB Stroke 19 Initial management of acute stroke (Cont’d) BP should not lowered unless >220/120 or heart failure in ischemic infarction whereas in hgic stroke, lower it to average TTT of hypoglycemia or hyperglycemia >180 mg%, O2 for hypoxemia, monitor for cerebral edema & seizures Stroke units: save lives & improves outcome. They should be used if available Prof. DAHAB Stroke 20 THROMBOLYTIC TREATMENT 1. 2. 3. 4. 5. Stroke recognition : pt + family + emergency services Should be offered if: Diagnosis of acute ischemic stroke Interval between onset & TTT <3 hours Acute focal neurological deficit Neurologist is consulted & participates in the treatment Brain CT Scan is obtained & interpreted by expertise Prof. DAHAB Stroke 21 THROMBOLYTIC TREATMENT (Cont’d) SHOULD NOT BE OFFERED IF: 1.Time of onset is unclear 2.BP > 185/110 3.CT Scan shows evidence of hge 4.Neurologic deficits improve spontaneously 5.Risk for hge Prof. DAHAB Stroke 22 TIA’s: DIAGNOSIS & MANAGEMENT TIA’S are warning signs of stroke. Management prevents disability & death Rate of stroke after TIA is 50% in 2 yrs, 70% of them in the 1st year. Risk is very high for stroke in the first 10 days after TIAs ⇒ URGENT EVALUATION Prof. DAHAB Stroke 23 DIAGNOSTIC WORK-UP Based on age, presentation, risk factors & intent to treat Head CT Noninvasive carotid artery evaluation TCD MRI & MRA Coagulopathy tests: protein C & S, antiphospholipid Abs, antithrombin III deficiency LP in suspected SAH with nondiagnostic CT Early angiography for aneurysm repair PET & SPECT Prof. DAHAB Stroke 24 ROLE OF ANTICOAGULATION Preventing recurrent cardioembolic stroke AF, recent MI, valvular disease, patent FO Heparin for 48 hrs before replaced by Warfarin Aspirin alone ⇓ risk of further AF emboli Anticoagulation is of no benefit in completed stroke Prof. DAHAB Stroke 25 ROLE OF NEURO-PROTECTIVE AGENTS Potential role in interrupting the cascade of molecular events leading to neuron death Ca Ch. Blockers, glutamate antagonists, Na Ch. Blockers, glycine antagonists, Opioid antagonists & antioxidants / free radical scavengers Little evidence in ⇓ size of infarction & improving outcome Prof. DAHAB Stroke 26 COMPLICATIONS OF ACUTE STROKE DVT Pulmonary embolism Aspiration pneumonia Urinary tract infection Decubitus ulcers Neurologically: Cerebral edema + seizures + hgic transformation Brain stem herniation: TTT by hyperventilation, osmotic therapy or even surgery. Steroids are not effective. Prof. DAHAB Stroke 27 CAROTID ENDARTERECTOMY Decreases risk of subsequent stroke Confirmed stenosis >70% No benefit in patients with <50 % Consider surgical skill 50-70% : individualized decision (ulcerated plaque) Prof. DAHAB Stroke 28 Carotid Endarterectomy ⇑ risk of complications with ⇑ age Safe & effective as for general population In prohibitive surgery ⇒ TTT with antiplatelet agents Prof. DAHAB Stroke 29 MEDICAL THERAPY agents: Aspirin ⇒ 25% ⇓ risk Optimal dose: ranging from 30mg-1300mg Ticlopidine & Clopidogrel: Two other platelet antiaggregants for 2ry prevention of stroke proved to be more effective than Aspirin Warfarin for prevention is unclear Dipyridamol & sulfinpyrazone ⇒ no effect Antiplatelet Prof. DAHAB Stroke 30 REHABILITATION AFTER STROKE Great proportion of patients survive with substantial neurologic impairment Goal of rehabilitation is not cure but rather adaptation to functional handicap To maximize function in the service of enhancing quality of life Physiatrist, physical therapist, occupational therapist and/or speech therapist Prof. DAHAB Stroke 31 REHABILITATION AFTER STROKE (Cont’d) Mild deficits do not need specialized rehabilitation services whereas patient who are stuporous, immobile, cognitively impaired or severely ill derive little benefit Success of rehabilitation efforts depends on neurological deficit, cognition, patient & family goals, social & psychological support Age is not a factor for rehabilitation outcome Prof. DAHAB Stroke 32 DEPRESSION AFTER STROKE Mood disturbances are common due to physical & psychological factors Depression plays a critical role in patient’s recovery. Prevalence : 25% to 50% (under-diagnosed) TTT with SSRI’s e.g. Sertraline, Paroxetine & Flextime Delirium with agitation & emotional incontinence distress patient, family & caregivers Prof. DAHAB Stroke 33 maggodd@yahoo.com Thank you Prof. DAHAB Stroke 34 Stroke Prof. Magdy Dahab, MD Azhar University May 11th, 2006